Fig. (8) The numerical value of alkali-labile/oxidative DNA damages of PBLs from normal patients (the control group) being a blood donors of Regional Centers of Blood Donation and Blood Therapy, and PBLs from CVI patients applying (one tablet twice a day) and not applying Detralex (**p < 0.001 vs. control).